Personnel News

NEW YORK--(BUSINESS WIRE)--GID, a vertically-integrated real estate owner, operator, developer and investor with $32.8 billion in assets under management, today announced the continued expansion of GID Residential Partners, its national development platform, with a strategic entry into the Boston market. The initiative will be led by industry veteran Chris Spendley, who joins the firm as Managing Director. Building on GID’s longstanding multifamily development experience, the growth within Bost...

PARIS--(BUSINESS WIRE)--The Combined Shareholders’ Meeting of TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) was held on May 29, 2026, under the chairmanship of Mr. Patrick Pouyanné. The shareholders adopted all the resolutions supported by the Board of Directors, including in particular: Approval of the 2025 financial statements and payment of a dividend of €3.40 per share for that fiscal year, Renewal of a three-year term as Directors for Ms. Marie-Christine Coisne-Roquette, Ms. Anelise La...

BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Mon courtier énergie group (code ISIN : FR001400H3A0 - Ticker symbol: ALMCE), an energy brokerage firm for businesses, announced today a change in corporate governance approved by the Board of Directors on May 29, 2026. On May 29, 2026, the Board of Directors unanimously decided to appoint Hugo LARRICQ as Chairman of the Board of Directors to replace Charlie EVRARD, who has resigned. This transition was prepared by Charlie EVRARD, who proposed...

NEW YORK--(BUSINESS WIRE)--UBS Wealth Management USA today announced two leadership appointments in its Southeast Wealth Management Region. The Southeast Region, which has seen an influx of wealth in recent years, encompasses some of the nation’s fastest growing wealth centers, including Philadelphia, Washington, D.C., Charlotte, Charleston, Nashville, Atlanta, Miami, Palm Beach, Naples and Tampa, among others. John Houlihan has been named Market Executive for the South Market. He is responsibl...

NEW YORK--(BUSINESS WIRE)--Equity Data Science (EDS), a leading provider of Investment Process Management (IPM) solutions for hedge funds and asset managers, today announced the appointment of Sebastian Lonza, CFA, CAIA as Chief Revenue Officer (CRO). Lonza joins EDS with deep expertise across portfolio analytics, risk management, and enterprise technology, bringing over a decade of experience helping institutional investors modernize their investment workflows. Prior to joining EDS, Lonza serv...

HOUSTON--(BUSINESS WIRE)--Chevron Corporation (NYSE: CVX) today announced the appointment of Scott A. Keller as general counsel. Keller, 44, will join Chevron on July 1 as general counsel, and will report to Chevron’s current chief legal officer, R. Hewitt Pate, in anticipation of Pate’s expected retirement in mid-2027 after 17 years of service. Upon his expected appointment to the position of chief legal officer, effective January 1, 2027, Keller will lead the company’s worldwide legal affairs...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akkio appoints Christian Juhl, ex-global CEO of GroupM ($60B+ media spend), to its board to accelerate agentic AI across top media companies....

ITHACA, N.Y.--(BUSINESS WIRE)--Tompkins Community Bank (Tompkins) is pleased to announce the appointment of John Huhtala as president of its Central New York market. In this role, Huhtala will lead the company’s market presence, with a focus on strengthening client relationships, expanding business development efforts, deepening community engagement and supporting collaboration across the organization. Huhtala brings more than 28 years of commercial banking, sales leadership and relationship ma...

AUSTIN, Texas--(BUSINESS WIRE)--PanTher Therapeutics (“PanTher” or the “Company”), a clinical-stage company redefining early cancer treatment with therapeutic implants administered directly at the tumor site, today announced that it has concluded the dose escalation portion of its Phase 1b clinical trial of PTM-101 in pancreatic ductal adenocarcinoma (PDAC). PanTher has identified the PTM-101 400mg paclitaxel-containing implant as the recommended Phase 2 dose (RP2D) in combination with neoadjuv...

SANTERAMO IN COLLE, Bari, Italy--(BUSINESS WIRE)--NATUZZI ANNOUNCES RESIGNATION OF A BOARD MEMBER, PIETRO LABRIOLA...